You are here

Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply.

Pubmed ID: 
30401441
Year: 
2018
Month: 
Nov
Volume: 
5
Issue: 
11
Citation: 
Cipriani A, Adamo N, Giovane CD, Coghill D, Banaschewski T, Hollis C, Zuddas A, Simonoff E, Cortese S. Unbalanced risk-benefit analysis of ADHD drugs - Authors' reply. The lancet. Psychiatry 5 (11) : 871 - 873(2018) PubMed